Todd A. Davies
Johnson & Johnson Pharmaceutical Research and Development
LLC, Room B225
1000 Route 202
USA
Name/email consistency: high
- Characterization and dynamics of middle ear fluid and nasopharyngeal isolates of Streptococcus pneumoniae from 12 children treated with levofloxacin. Davies, T.A., Leibovitz, E., Noel, G.J., McNeeley, D.F., Bush, K., Dagan, R. Antimicrob. Agents Chemother. (2008)
- Decline in the prevalence of pandemic clones Spain23F-1 and Spain9V-3 among US fluoroquinolone-resistant Streptococcus pneumoniae TRUST Surveillance isolates since 2001. Davies, T.A., Yee, Y.C., Goldschmidt, R., Sahm, D.F., Evangelista, A.T. Postgrad. Med (2008)
- Sporadic occurrences of fluoroquinolone-resistant Streptococcus pneumoniae in the United States: longitudinal analysis of institutions from the New England and West South Central regions during the TRUST 4-9 (2000-2005) Surveillance Studies. Davies, T.A., Yee, Y.C., Amsler, K., Goldschmidt, R., Sahm, D.F., Evangelista, A.T. Postgrad. Med (2008)
- Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa. Davies, T.A., Shang, W., Bush, K., Flamm, R.K. Antimicrob. Agents Chemother. (2008)
- Effects of the 7-valent pneumococcal conjugate vaccine on U.S. levofloxacin-resistant Streptococcus pneumoniae. Davies, T.A., Yee, Y.C., Bush, K., Sahm, D., Evangelista, A., Goldschmidt, R. Microb. Drug Resist. (2008)
- Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. Davies, T.A., Page, M.G., Shang, W., Andrew, T., Kania, M., Bush, K. Antimicrob. Agents Chemother. (2007)
- Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003). Davies, T.A., Yee, Y.C., Goldschmidt, R., Bush, K., Sahm, D.F., Evangelista, A. J. Antimicrob. Chemother. (2006)
- Activities of ceftobiprole and other beta-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x. Davies, T.A., Shang, W., Bush, K. Antimicrob. Agents Chemother. (2006)
- Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000. Davies, T.A., Bush, K., Sahm, D., Evangelista, A. Antimicrob. Agents Chemother. (2005)
- Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000). Davies, T.A., Goldschmidt, R., Pfleger, S., Loeloff, M., Bush, K., Sahm, D.F., Evangelista, A. J. Antimicrob. Chemother. (2003)
- Screening of large numbers of Streptococcus pneumoniae isolates for mutations associated with fluoroquinolone resistance using an oligonucleotide probe assay. Davies, T.A., Goldschmidt, R. FEMS Microbiol. Lett. (2002)
